BioCryst Receives European Commission Approval of ORLADEYO™ (berotralstat), First Oral, Once-daily Therapy to Prevent Attacks in Hereditary Angioedema Patients
RESEARCH TRIANGLE PARK, N.C., April 30, 2021 (GLOBE NEWSWIRE) — BioCryst Pharmaceuticals, Inc. (Nasdaq: BCRX)…
Lithosphere Deploys MultX to Enable Atomic Cross-Chain Execution on Makalu
American Aires Inc. Announces Change of Auditor
Zhibao Technology Announces 1H2026 Earnings Conference Call and Investor Webinar Participation
Integrated Quantum Technologies Announces Non-Brokered Private Placement of Units
TechCon Global Announces Dr. Irwin Jacobs as Recipient of the TechCon Fellows Lifetime Achievement Award